Ireland
--:--IST
Recruiting Observational

Gait Assessment Via Telephone Application

NCT06157749 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2024-07-31
Last updated
2025-03-24

Condition(s) studied

Health, Subjective

Investigational drug(s) / intervention(s)

Gait analysis

Gait analysis: It will be carried out on a 10-meter flat surface, with the participant walking at normal walking speed.

Study summary

The evaluation of human gait is a crucial component of the clinical assessment and decision-making process. The gold standard in gait analysis is computerized gait analysis, which allows for three-dimensional digital data acquisition through computers (3D Computerized Gait Analysis). However, this technology is not readily accessible in routine analyses, as it proves to be a time-consuming and expensive endeavor in terms of infrastructure and human resources. The utilization of smartphones in clinical applications is on the rise, facilitated by the increasing accessibility of low-cost or free "applications," thereby addressing the limitations associated with traditional gait analysis methods. The Gait-Analyzer application is among the mentioned applications. However, in the literature, no evidence has been found regarding the validity and reliability of Gait-Analyzer application compared to the gold standard 3D computerized gait analysis systems within the context of gait analyses.

The aim of this study is to comparatively examine the effectiveness of the Gait-Analyzer smartphone application with established 3D Computerized Gait Analysis systems, which have proven validity and reliability in gait analyses. Through this research, the study intends to elucidate the validity and reliability of spatiotemporal parameters of walking within the Gait-Analyzer smartphone application.

Eligibility

Sex
ALL
Min age
18 Years
Max age
26 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 18 and 26 years. * Body Mass Index (BMI) within normal limits (18.5-24.9 kg/m2) Exclusion Criteria: * Presence of lower extremity rotational problems (such as high femoral anteversion, internal tibial torsion, metatarsus adductus). * History of Botulinum Toxin Type A (BoNT-A) application or surgery within the last 6 months. * History of lower extremity injury within the last 6 months. * Leg length discrepancy. * Presence of third-degree pes planus. * Any neurological, rheumatic, musculoskeletal, metabolic, or connective tissue diseases. * History of pain, deformity, or surgery related to the vertebral column and upper extremities. * Presence of cognitive, mental, and/or severe psychiatric disorders

Primary outcome measure(s)

  • Three-Dimensional Computerized Gait Analysis — change from baseline at first week
    Reflective markers are placed on specific anatomical points to record varying joint angles throughout the walking cycle. Patients walk a distance of 9-10 meters, capturing records of their walking patterns and speed in everyday life, either barefoot or using assistive walking devices.
  • Gait-Analyzer — change from baseline at first week
    Gait-Analyzer is a mobile application for smartphones capable of real-time analysis of walking parameters. Using a smartphone with an Android processor and the "Gait Analyzer" application, directly attached to the participants' lumbar spine (nearest to L5) with a waist belt, participants will be instructed to complete 6 laps (12 forward and backward walks) on a 10-meter walking path.

Trial sites (1)

FacilityCityRegionStatus
Acibadem Mehmet Ali Aydinlar University Istanbul Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06157749 on ClinicalTrials.gov ↗ ← All trials in Turkey